An Atomic-Level Perspective of HMG-Coa-Reductase
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Characterization of a Microsomal Retinol Dehydrogenase Gene from Amphioxus: Retinoid Metabolism Before Vertebrates
Chemico-Biological Interactions 130–132 (2001) 359–370 www.elsevier.com/locate/chembiont Characterization of a microsomal retinol dehydrogenase gene from amphioxus: retinoid metabolism before vertebrates Diana Dalfo´, Cristian Can˜estro, Ricard Albalat, Roser Gonza`lez-Duarte * Departament de Gene`tica, Facultat de Biologia, Uni6ersitat de Barcelona, A6. Diagonal, 645, E-08028, Barcelona, Spain Abstract Amphioxus, a member of the subphylum Cephalochordata, is thought to be the closest living relative to vertebrates. Although these animals have a vertebrate-like response to retinoic acid, the pathway of retinoid metabolism remains unknown. Two different enzyme systems — the short chain dehydrogenase/reductases and the cytosolic medium-chain alcohol dehydrogenases (ADHs) — have been postulated in vertebrates. Nevertheless, recent data show that the vertebrate-ADH1 and ADH4 retinol-active forms originated after the divergence of cephalochordates and vertebrates. Moreover, no data has been gathered in support of medium-chain retinol active forms in amphioxus. Then, if the cytosolic ADH system is absent and these animals use retinol, the microsomal retinol dehydrogenases could be involved in retinol oxidation. We have identified the genomic region and cDNA of an amphioxus Rdh gene as a preliminary step for functional characterization. Besides, phyloge- netic analysis supports the ancestral position of amphioxus Rdh in relation to the vertebrate forms. © 2001 Elsevier Science Ireland Ltd. All rights reserved. Keywords: Retinol dehydrogenase; Retinoid metabolism; Amphioxus * Corresponding author. Fax: +34-93-4110969. E-mail address: [email protected] (R. Gonza`lez-Duarte). 0009-2797/01/$ - see front matter © 2001 Elsevier Science Ireland Ltd. All rights reserved. PII: S0009-2797(00)00261-1 360 D. -
Methionine Sulfoxide Reductase a Is a Stereospecific Methionine Oxidase
Methionine sulfoxide reductase A is a stereospecific methionine oxidase Jung Chae Lim, Zheng You, Geumsoo Kim, and Rodney L. Levine1 Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, Bethesda, MD 20892-8012 Edited by Irwin Fridovich, Duke University Medical Center, Durham, NC, and approved May 10, 2011 (received for review February 10, 2011) Methionine sulfoxide reductase A (MsrA) catalyzes the reduction Results of methionine sulfoxide to methionine and is specific for the S epi- Stoichiometry. Branlant and coworkers have studied in careful mer of methionine sulfoxide. The enzyme participates in defense detail the mechanism of the MsrA reaction in bacteria (17, 18). against oxidative stresses by reducing methionine sulfoxide resi- In the absence of reducing agents, each molecule of MsrA dues in proteins back to methionine. Because oxidation of methio- reduces two molecules of MetO. Reduction of the first MetO nine residues is reversible, this covalent modification could also generates a sulfenic acid at the active site cysteine, and it is function as a mechanism for cellular regulation, provided there reduced back to the thiol by a fast reaction, which generates a exists a stereospecific methionine oxidase. We show that MsrA disulfide bond in the resolving domain of the protein. The second itself is a stereospecific methionine oxidase, producing S-methio- MetO is then reduced and again generates a sulfenic acid at the nine sulfoxide as its product. MsrA catalyzes its own autooxidation active site. Because the resolving domain cysteines have already as well as oxidation of free methionine and methionine residues formed a disulfide, no further reaction forms. -
Estrogen Receptor-Mediated Neuroprotection: the Role of the Alzheimer’S Disease-Related Gene Seladin-1
REVIEW Estrogen receptor-mediated neuroprotection: The role of the Alzheimer’s disease-related gene seladin-1 Alessandro Peri Abstract: Experimental evidence supports a protective role of estrogen in the brain. According Mario Serio to the fact that Alzheimer’s disease (AD) is more common in postmenopausal women, estrogen treatment has been proposed. However, there is no general consensus on the benefi cial effect of Department of Clinical Physiopathology, Endocrine Unit, estrogen or selective estrogen receptor modulators in preventing or treating AD. It has to be said that Center for Research, Transfer several factors may markedly affect the effi cacy of the treatment. A few years ago, the seladin-1 gene and High Education on Chronic, Inflammatory, Degenerative (for selective Alzheimer’s disease indicator-1) has been isolated and found to be down-regulated and Neoplastic Disorders in brain regions affected by AD. Seladin-1 has been found to be identical to the gene encoding the for the Development of Novel enzyme 3-beta-hydroxysterol delta-24-reductase, involved in the cholesterol biosynthetic pathway, Therapies (DENOThe), University β of Florence, Florence, Italy which confers protection against -amyloid-mediated toxicity and from oxidative stress, and is an effective inhibitor of caspase-3 activity, a key mediator of apoptosis. Interestingly, we found earlier that the expression of this gene is up-regulated by estrogen. Furthermore, our very recent data support the hypothesis that seladin-1 is a mediator of the neuroprotective effects of estrogen. This review will summarize the current knowledge regarding the neuroprotective effects of seladin-1 and the relationship between this protein and estrogen. -
Table S1. Disease Classification and Disease-Reaction Association
Table S1. Disease classification and disease-reaction association Disorder class Associated reactions cross Disease Ref[Goh check et al. -
A Brief Guide to Enzyme Classification and Nomenclature Rev AM
A Brief Guide to Enzyme Nomenclature and Classification Keith Tipton and Andrew McDonald 1) Introduction NC-IUBMB Enzyme List, or, to give it its full title, “Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes by the Reactions they Catalyse,1 is a functional system, based solely on the substrates transformed and products formed by an enzyme. The basic layout of the classification for each enzyme is described below with some indication of the guidelines followed. More detailed rules for enzyme nomenclature and classification are available online.2 Further details of the principles governing the nomenclature of individual enzyme classes are given in the following sections. 2. Basic Concepts 2.1. EC numbers Enzymes are identified by EC (Enzyme Commission) numbers. These are also valuable for relating the information to other databases. They were divided into 6 major classes according to the type of reaction catalysed and a seventh, the translocases, was added in 2018.3 These are shown in Table 1. Table 1. Enzyme classes Name Reaction catalysed 1 Oxidoreductases *AH2 + B = A +BH2 2 Transferases AX + B = BX + A 3 Hydrolases A-B + H2O = AH + BOH 4 Lyases A=B + X-Y = A-B ç ç X Y 5 Isomerases A = B 6 LiGases †A + B + NTP = A-B + NDP + P (or NMP + PP) 7 Translocases AX + B çç = A + X + ççB (side 1) (side 2) *Where nicotinamide-adenine dinucleotides are the acceptors, NAD+ and NADH + H+ are used, by convention. †NTP = nucleoside triphosphate. The EC number is made up of four components separated by full stops. -
Effects of DHCR24 Depletion in Vivo and in Vitro
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2006 Effects of DHCR24 depletion in vivo and in vitro Kuehnle, Katrin Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-163476 Dissertation Published Version Originally published at: Kuehnle, Katrin. Effects of DHCR24 depletion in vivo and in vitro. 2006, University of Zurich, Faculty of Science. Effects of DHCR24 Depletion in vivo and in vitro Dissertation zur Erlangung der naturwissenschaftlichen Doktorwürde (Dr. sc. nat) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät der Universität Zürich von Katrin Kuehnle aus Deutschland Promotionskommitee Prof. Esther Stöckli (Vorsitz) PD Dr. M. Hasan Mohajeri (Leitung der Dissertation) Prof. Alex Hajnal Zürich, 2006 It is almost precisely 100 years ago that Auguste D. reported to a German psychiatrist in Frankfurt with the words: ‘I lost myself’. The psychiatrist was none other than Alois Alzheimer, and this day should mark the beginning of Alzheimer’s disease research. Christian Haass, 2004 SUMMARY 9 ZUSAMMENFASSUNG 11 1. INTRODUCTION 13 1.1 ALZHEIMER’S DISEASE 13 1.1.1 THE DISEASE HYPOTHESES 14 1.1.2 APP PROCESSING 15 1.1.3 FAMILIAL ALZHEIMER’S DISEASE (FAD) 17 1.1.4 GENETIC AND NON-GENETIC RISK FACTORS FOR AD 17 1.1.5 CLEARANCE OF AΒETA FROM THE BRAIN 18 1.1.6 TREATMENTS AND POSSIBLE TREATMENT STRATEGIES OF AD 19 1.2 CHOLESTEROL AND AD 21 1.2.1 METABOLISM OF CHOLESTEROL 22 1.2.2 BRAIN CHOLESTEROL 24 1.2.3 CELLULAR MEMBRANES AND LIPID RAFTS 25 1.2.4 CHOLESTEROLS’ INFLUENCE ON APP PROCESSING 26 1.2.5 CHOLESTEROL BIOSYNTHESIS AND TRANSPORT DISORDERS 27 1.2.6 DHCR24 KNOCK-OUT MICE 28 1.2.7 DHCR24/SELADIN-1 29 1.3 AIM OF THE STUDY 31 2. -
Prenatalscreen® Standard Technical Report
About PrenatalScreen® Prenatal Test PrenatalScreen® Prenatal Test is a genetic test that analyses fetal DNA, obtained from CVS or amniotic fluid following an invasive prenatal diagnosis, to screen for monogenic disorders in the fetus. Using the latest technologies, including Next Generation Sequencing (NGS), PrenatalScreen® Prenatal Test screen 744 genes for mutations causing over 1.000 severe genetic disorders in the fetus. PrenatalScreen® Prenatal Test allows for a comprehensive care and enables patients to make more informed reproductive decisions. Offering PrenatalScreen® Prenatal Test to a patient during pregnancy allows her to gain more knowledge about the potential to pass along a condition to the fetus. Aim of the test PrenatalScreen® Prenatal Test analyses DNA extracted from fetal cells in the amniotic fluid, collected through amniocentesis, or in the chorionic villi through villocentesis (CVS). The aim of this diagnositc test is to assess severe genetic diseases in the fetus, including the most common diseases in the European population. Genes listed in Table 1 were selected according to the incidence in the population of the disease caused by mutations in such genes, the severity of the clinical phenotype at birth and the importance of the related pathogenetic picture, in accordance with the indications of the American College of Medical Genetics (ACMG)(Grody et al., Genet Med 2013:15:482–483). PrenatalScreen®: Indication for testing PrenatalScreen® Prenatal Test is intended for patients who meet any of the following criteria: • Personal/familial anamnesis of hereditary genetic diseases; • For expectant mothers wishing to reduce the risk of a genetic diseases in the fetus; • For natural or in vitro fertilization (IVF)-derived pregnancies: • For couples using heterologus IVF procedures (egg/sperm donors). -
Steroidal Triterpenes of Cholesterol Synthesis
Molecules 2013, 18, 4002-4017; doi:10.3390/molecules18044002 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Steroidal Triterpenes of Cholesterol Synthesis Jure Ačimovič and Damjana Rozman * Centre for Functional Genomics and Bio-Chips, Faculty of Medicine, Institute of Biochemistry, University of Ljubljana, Zaloška 4, Ljubljana SI-1000, Slovenia; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +386-1-543-7591; Fax: +386-1-543-7588. Received: 18 February 2013; in revised form: 19 March 2013 / Accepted: 27 March 2013 / Published: 4 April 2013 Abstract: Cholesterol synthesis is a ubiquitous and housekeeping metabolic pathway that leads to cholesterol, an essential structural component of mammalian cell membranes, required for proper membrane permeability and fluidity. The last part of the pathway involves steroidal triterpenes with cholestane ring structures. It starts by conversion of acyclic squalene into lanosterol, the first sterol intermediate of the pathway, followed by production of 20 structurally very similar steroidal triterpene molecules in over 11 complex enzyme reactions. Due to the structural similarities of sterol intermediates and the broad substrate specificity of the enzymes involved (especially sterol-Δ24-reductase; DHCR24) the exact sequence of the reactions between lanosterol and cholesterol remains undefined. This article reviews all hitherto known structures of post-squalene steroidal triterpenes of cholesterol synthesis, their biological roles and the enzymes responsible for their synthesis. Furthermore, it summarises kinetic parameters of enzymes (Vmax and Km) and sterol intermediate concentrations from various tissues. Due to the complexity of the post-squalene cholesterol synthesis pathway, future studies will require a comprehensive meta-analysis of the pathway to elucidate the exact reaction sequence in different tissues, physiological or disease conditions. -
SELENOF) with Retinol Dehydrogenase 11 (RDH11
Tian et al. Nutrition & Metabolism (2018) 15:7 DOI 10.1186/s12986-017-0235-x RESEARCH Open Access The interaction of selenoprotein F (SELENOF) with retinol dehydrogenase 11 (RDH11) implied a role of SELENOF in vitamin A metabolism Jing Tian1* , Jiapan Liu1, Jieqiong Li2, Jingxin Zheng3, Lifang Chen4, Yujuan Wang1, Qiong Liu1 and Jiazuan Ni1 Abstract Background: Selenoprotein F (SELENOF, was named as 15-kDa selenoprotein) has been reported to play important roles in oxidative stress, endoplasmic reticulum (ER) stress and carcinogenesis. However, the biological function of SELENOF is still unclear. Methods: A yeast two-hybrid system was used to screen the interactive protein of SELENOF in a human fetal brain cDNA library. The interaction between SELENOF and interactive protein was validated by fluorescence resonance energy transfer (FRET), co-immunoprecipitation (co-IP) and pull-down assays. The production of retinol was detected by high performance liquid chromatograph (HPLC). Results: Retinol dehydrogenase 11 (RDH11) was found to interact with SELENOF. RDH11 is an enzyme for the reduction of all-trans-retinaldehyde to all-trans-retinol (vitamin A). The production of retinol was decreased by SELENOF overexpression, resulting in more retinaldehyde. Conclusions: SELENOF interacts with RDH11 and blocks its enzyme activity to reduce all-trans-retinaldehyde. Keywords: SELENOF (Seleonoprotein F) , Yeast two hybrid system, Protein-protein interaction, Retinol dehydrogenase 11 (RDH11), Fluorescence resonance energy transfer (FRET), Co-immunoprecipitation (co-IP), Pull- down, Retinol (vitamin a), Retinaldehyde Background SELENOF shows that the protein contains a Selenium (Se) is a necessary trace element for human thioredoxin-like motif. The redox potential of this motif health. -
Disorders of Cholesterol Biosynthesis
Arch Dis Child 1998;78:185–189 185 CURRENT TOPIC Arch Dis Child: first published as 10.1136/adc.78.2.185 on 1 February 1998. Downloaded from Disorders of cholesterol biosynthesis Peter T Clayton Functions of cholesterol Studies with labelled cholesterol indicate that, Sterols are important constituents of the cell although as much as 20% of fetal cholesterol membranes of most eukaryotic cells. The cell may be derived from the mother at the end of membranes of terrestrial vertebrates, including the first trimester, very little maternal man, contain a single major sterol species— cholesterol enters the fetal brain.56 If the cholesterol. Cholesterol is found particularly in mother is given labelled glucose, the label does external cellular membranes (plasma mem- appear in fetal brain cholesterol and glucose is branes) and in the layers that make up the thought to be the most important fuel for de myelin sheaths in the central and peripheral novo cholesterol synthesis in the fetal brain. In nervous systems. In plasma membranes, the postnatal life, a high cholesterol diet will lead to cholesterol molecules are intercalated between reduced synthesis of cholesterol in the liver. the phospholipid molecules of each monolayer This occurs principally as a result of inhibition and reduce the movement of their acyl chains of the rate limiting step, 3-hydroxy-3-methyl- (reduced “membrane fluidity”). Sterols also CoA (HMG-CoA) reductase, by cholesterol. exert a direct eVect on proteins in the In extrahepatic tissues, the uptake of lipopro- membrane. For example, the function of the tein cholesterol switches oV cholesterol synthe- human red cell hexose transporter is pro- sis in the same way. -
Pyruvate Ferredoxin Oxidoreductase from the Hyperthermophilic
Proc. Natl. Acad. Sci. USA Vol. 94, pp. 9608–9613, September 1997 Biochemistry Pyruvate ferredoxin oxidoreductase from the hyperthermophilic archaeon, Pyrococcus furiosus, functions as a CoA-dependent pyruvate decarboxylase (archaeayaldehydeydecarboxylationy2-keto acidythiamine pyrophosphate) KESEN MA*, ANDREA HUTCHINS*, SHI-JEAN S. SUNG†, AND MICHAEL W. W. ADAMS*‡ *Center for Metalloenzyme Studies, Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602; and †Institute of Tree Root Biology, U.S. Department of Agriculture–Forest Service, Athens, GA 30602 Communicated by Gregory A. Petsko, Brandeis University, Waltham, MA, June 17, 1997 (received for review June 1, 1996) ABSTRACT Pyruvate ferredoxin oxidoreductase (POR) hyperthermophilic archaea and these are involved in peptide has been previously purified from the hyperthermophilic fermentation. They use 2-ketoglutarate (KGOR) (11), in- archaeon, Pyrococcus furiosus, an organism that grows opti- dolepyruvate (IOR) (12), and 2-ketoisovalerate (VOR) (13) as mally at 100°C by fermenting carbohydrates and peptides. The substrates, and function to oxidatively decarboxylate the 2- enzyme contains thiamine pyrophosphate and catalyzes the keto acids generated by the transamination of glutamate, oxidative decarboxylation of pyruvate to acetyl-CoA and CO2 aromatic amino acids, and branched chain amino acids, re- and reduces P. furiosus ferredoxin. Here we show that this spectively, to the corresponding CoA derivative (13). enzyme also catalyzes the formation of acetaldehyde from The growth of hyperthermophilic archaea such as P. furiosus pyruvate in a CoA-dependent reaction. Desulfocoenzyme A is also unusual in that it is dependent upon tungsten (14), a substituted for CoA showing that the cofactor plays a struc- metal seldom used in biological systems (15). -
A Nitrogenase-Like Methylthio-Alkane Reductase Complex Catalyzes Anaerobic Methane, Ethylene, and Methionine Biosynthesis Justin A
A Nitrogenase-like Methylthio-alkane Reductase Complex Catalyzes Anaerobic Methane, Ethylene, and Methionine Biosynthesis Justin A. North,1 Srividya Murali1* ([email protected]), Adrienne B. Narrowe,3 Weili Xiong,4 Kathryn M. Byerly,1 Sarah J. Young,1 Yasuo Yoshikuni,5 Sean McSweeney,6 Dale Kreitler,6 William R. Cannon,2 Kelly C. Wrighton,3 Robert L. Hettich,4 and F. Robert Tabita1 (former PI, deceased) 1Department of Microbiology, The Ohio State University, Columbus, OH; 2Pacific Northwest National Laboratory, Richland, WA. 3Department of Soil and Crop Sciences, Colorado State University, Fort Collins, CO; 4Chemical Sciences Division, ORNL, Oak Ridge, TN; 5DOE Joint Genome Institute, Berkeley, CA; 6NSLS-II, Brookhaven National Laboratory, Upton, NY. Project Goals: The goal of this project is to identify and characterize the specific enzyme(s) that catalyze anaerobic ethylene synthesis. This is part of a larger project to develop an industrially compatible microbial process to synthesize ethylene in high yields. The specific goals are: 1. Identify the genes and gene products responsible for anaerobic ethylene synthesis. 2. Probe the substrate specificity and metagenomic functional diversity of methylthio-alkane reductases to identify optimal bioproduct generating systems. 3. Characterize the enzymes and the reactions that directly generate anaerobic ethylene. Abstract Text: Our previous work identified a novel anaerobic microbial pathway (DHAP- Ethylene Shunt) [1] that recycled 5’-methylthioadenosine (MTA) back to methionine with stoichiometric amounts of ethylene produced as a surprising side-product. MTA is a metabolic byproduct of methionine utilization in a multitude of cellular processes. The initial steps of the DHAP-ethylene sequentially converts MTA to dihydroxyacetone phosphate (DHAP) and ethylene precursor (2-methylthio)ethanol (Fig.